Epigenetic modifications: Critical participants of the PD-L1 regulatory mechanism in solid tumors (Review)

Immune checkpoint inhibitors targeting the programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) axis have achieved marked and durable efficacy in patients with different solid tumors and have improved their survival. However, the presence of primary or acquired resistance to immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaoran, Wu, Jibiao, Wang, Bin, Liu, Cun, Liu, Lijuan, Sun, Changgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521627/
https://www.ncbi.nlm.nih.gov/pubmed/36129152
http://dx.doi.org/10.3892/ijo.2022.5424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521627/
https://www.ncbi.nlm.nih.gov/pubmed/36129152
http://dx.doi.org/10.3892/ijo.2022.5424

Ejemplares similares